There is only one clinical trial for lixisenatide in PD, assessing its efficacy in slowing motor disability progression in early-stage patients over 12 months, followed by a 2-month washout period
Our Nurse Practitioner will administer patients semaglutide injections
SGLT2 Inhibitors Evidence has been increasing to support the use of SGLT2 inhibitors in patients with heart failure
nevertheless, their most pronounced effect in obesity is appetite reduction through central nervous system (CNS) mechanisms, mainly within the hypothalamus [35]
Furthermore, our IRB follows the International Guideline for Human Research protection as required by the Declaration of Helsinki, The Belmont Report, CIOMS Guideline and the International Conference on Harmonization in Good Clinical Practice (ICH-GCP)
While the initial craze surrounding Ozempic may have simmered, it triggered almost immediate reactions in the market